One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension
Riddle, M. C., Yki-Järvinen, H., Bolli, G. B., Ziemen, M., Muehlen-Bartmer, I., Cissokho, S., Home, P. D.Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12472
Date:
May, 2015
File:
PDF, 503 KB
english, 2015